195 related articles for article (PubMed ID: 28391270)
1. Single Retinal Layer Evaluation in Patients with Type 1 Diabetes with No or Early Signs of Diabetic Retinopathy: The First Hint of Neurovascular Crosstalk Damage between Neurons and Capillaries?
Scarinci F; Picconi F; Virgili G; Giorno P; Di Renzo A; Varano M; Frontoni S; Parravano M
Ophthalmologica; 2017; 237(4):223-231. PubMed ID: 28391270
[TBL] [Abstract][Full Text] [Related]
2. Early microvascular retinal changes in optical coherence tomography angiography in patients with type 1 diabetes mellitus.
Simonett JM; Scarinci F; Picconi F; Giorno P; De Geronimo D; Di Renzo A; Varano M; Frontoni S; Parravano M
Acta Ophthalmol; 2017 Dec; 95(8):e751-e755. PubMed ID: 28211261
[TBL] [Abstract][Full Text] [Related]
3. Ability of Swept source OCT technology to detect neurodegeneration in patients with type 2 diabetes mellitus without diabetic retinopathy.
Satue M; Cipres M; Melchor I; Gil-Arribas L; Vilades E; Garcia-Martin E
Jpn J Ophthalmol; 2020 Jul; 64(4):367-377. PubMed ID: 32157484
[TBL] [Abstract][Full Text] [Related]
4. Retinal neurovascular changes appear earlier in type 2 diabetic patients.
Pierro L; Iuliano L; Cicinelli MV; Casalino G; Bandello F
Eur J Ophthalmol; 2017 May; 27(3):346-351. PubMed ID: 27791250
[TBL] [Abstract][Full Text] [Related]
5. Optical coherence tomography angiography analysis of retinal vascular plexuses and choriocapillaris in patients with type 1 diabetes without diabetic retinopathy.
Carnevali A; Sacconi R; Corbelli E; Tomasso L; Querques L; Zerbini G; Scorcia V; Bandello F; Querques G
Acta Diabetol; 2017 Jul; 54(7):695-702. PubMed ID: 28474119
[TBL] [Abstract][Full Text] [Related]
6. EARLY MICROVASCULAR AND NEURAL CHANGES IN PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES MELLITUS WITHOUT CLINICAL SIGNS OF DIABETIC RETINOPATHY.
Vujosevic S; Muraca A; Alkabes M; Villani E; Cavarzeran F; Rossetti L; De Cillaʼ S
Retina; 2019 Mar; 39(3):435-445. PubMed ID: 29206758
[TBL] [Abstract][Full Text] [Related]
7. Alterations in Retinal Layer Thickness and Reflectance at Different Stages of Diabetic Retinopathy by En Face Optical Coherence Tomography.
Wanek J; Blair NP; Chau FY; Lim JI; Leiderman YI; Shahidi M
Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT341-7. PubMed ID: 27409491
[TBL] [Abstract][Full Text] [Related]
8. Identifying Microvascular and Neural Parameters Related to the Severity of Diabetic Retinopathy Using Optical Coherence Tomography Angiography.
Li X; Xie J; Zhang L; Cui Y; Zhang G; Chen X; Wang J; Zhang A; Huang T; Meng Q
Invest Ophthalmol Vis Sci; 2020 May; 61(5):39. PubMed ID: 32441757
[TBL] [Abstract][Full Text] [Related]
9. Vascular Changes and Neurodegeneration in the Early Stages of Diabetic Retinopathy: Which Comes First?
Jonsson KB; Frydkjaer-Olsen U; Grauslund J
Ophthalmic Res; 2016; 56(1):1-9. PubMed ID: 27035578
[TBL] [Abstract][Full Text] [Related]
10. Neurodegeneration in Type 2 Diabetes: Evidence From Spectral-Domain Optical Coherence Tomography.
Chhablani J; Sharma A; Goud A; Peguda HK; Rao HL; Begum VU; Barteselli G
Invest Ophthalmol Vis Sci; 2015 Oct; 56(11):6333-8. PubMed ID: 26436886
[TBL] [Abstract][Full Text] [Related]
11. Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes.
van Dijk HW; Verbraak FD; Kok PH; Garvin MK; Sonka M; Lee K; Devries JH; Michels RP; van Velthoven ME; Schlingemann RO; Abràmoff MD
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3660-5. PubMed ID: 20130282
[TBL] [Abstract][Full Text] [Related]
12. RETINAL MORPHOMETRY CHANGES MEASURED WITH SPECTRAL DOMAIN-OPTICAL COHERENCE TOMOGRAPHY AFTER PAN-RETINAL PHOTOCOAGULATION IN PATIENTS WITH PROLIFERATIVE DIABETIC RETINOPATHY.
Mitsch C; Pemp B; Kriechbaum K; Bolz M; Scholda C; Schmidt-Erfurth U
Retina; 2016 Jun; 36(6):1162-9. PubMed ID: 26562565
[TBL] [Abstract][Full Text] [Related]
13. Retinal Tissue Thickness is Reduced in Diabetic Peripheral Neuropathy.
Srinivasan S; Pritchard N; Vagenas D; Edwards K; Sampson GP; Russell AW; Malik RA; Efron N
Curr Eye Res; 2016 Oct; 41(10):1359-1366. PubMed ID: 26928267
[TBL] [Abstract][Full Text] [Related]
14. Changes in retinal layers in type 1 diabetes mellitus without retinopathy measured by spectral domain and swept source OCTs.
Orduna-Hospital E; Sanchez-Cano A; Perdices L; Acha J; Lopez-Alaminos EM; Pinilla I
Sci Rep; 2021 May; 11(1):10427. PubMed ID: 34001996
[TBL] [Abstract][Full Text] [Related]
15. German Diabetes Study - Baseline data of retinal layer thickness measured by SD-OCT in early diabetes mellitus.
Schröder K; Szendroedi J; Benthin A; Gontscharuk V; Ackermann P; Völker M; Steingrube N; Nowotny B; Ziegler D; Müssig K; Geerling G; Kuß O; Roden M; Guthoff R;
Acta Ophthalmol; 2019 Mar; 97(2):e303-e307. PubMed ID: 30238609
[TBL] [Abstract][Full Text] [Related]
16. Foveal ganglion cell layer damage in ischemic diabetic maculopathy: correlation of optical coherence tomographic and anatomic changes.
Byeon SH; Chu YK; Lee H; Lee SY; Kwon OW
Ophthalmology; 2009 Oct; 116(10):1949-59.e8. PubMed ID: 19699533
[TBL] [Abstract][Full Text] [Related]
17. The effect of fenofibrate on early retinal nerve fiber layer loss in type 2 diabetic patients: a case-control study.
Shi R; Zhao L; Qi Y
BMC Ophthalmol; 2018 Apr; 18(1):100. PubMed ID: 29669526
[TBL] [Abstract][Full Text] [Related]
18. Neurodegeneration of the retina in type 1 diabetic patients.
Araszkiewicz A; Zozulińska-Ziółkiewicz D; Meller M; Bernardczyk-Meller J; Piłaciński S; Rogowicz-Frontczak A; Naskręt D; Wierusz-Wysocka B
Pol Arch Med Wewn; 2012; 122(10):464-70. PubMed ID: 22910230
[TBL] [Abstract][Full Text] [Related]
19. Correlation between corneal and retinal neurodegenerative changes and their association with microvascular perfusion in type II diabetes.
Hafner J; Karst S; Sacu S; Scholda C; Pablik E; Schmidt-Erfurth U
Acta Ophthalmol; 2019 Jun; 97(4):e545-e550. PubMed ID: 30311432
[TBL] [Abstract][Full Text] [Related]
20. Pilot Study of Eyesight Characteristics and Thickness of the Retinal Nerve Fiber and Ganglion Cell-inner Plexiform Layers in Adolescent Patients with Type one Diabetes Mellitus on an Insulin Pump.
Raczyńska D; Bzoma B; Sielachowicz K; Brandt A; Chomińska-Dorn D; Raczyńska K; Glasner L; Dębska-Ślizień A; Myśliwiec M
Curr Pharm Des; 2018; 24(27):3264-3275. PubMed ID: 30246633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
